BridgeBio Oncology Therapeutics, Inc. (BBOT) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading BBOT…

BridgeBio Oncology Therapeutics, Inc. (BBOT) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

BridgeBio Oncology Therapeutics, Inc.

BBOT · CIK 1869105

4 · Oct 5, 2026 · COO & Principal Financial Ofcr Elmelech Idan reported 343 shares

4

COO & Principal Financial Ofcr Elmelech Idan reported 343 shares

Filed: Oct 5, 2026
Period: Oct 1, 2026
Accession: 0001193125-26-414131
Filer: BridgeBio Oncology Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov